Evaluating Outcomes of Mother-Infant Pairs Using Dolutegravir for Treatment of HIV During Pregnancy

BACKGROUND: Dolutegravir (DTG) is a highly efficacious and well tolerated antiretroviral (ART) for the treatment of HIV infection. Although on the preferred treatment list for people living with HIV, it is not a treatment option for pregnant women because data on efficacy, tolerability during pregna...

Descripción completa

Detalles Bibliográficos
Autores principales: Sibliss, Kedesha, Kirby, Olivia, Nkwihoreze, Hervette, Aaron, Erika, Alleyne, Gregg, Momplaisir, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631320/
http://dx.doi.org/10.1093/ofid/ofx163.1775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631320/
http://dx.doi.org/10.1093/ofid/ofx163.1775

Ejemplares similares